Dabigatran GI Bleeding: Risks, Signs, and What to Do

When you take dabigatran, a direct oral anticoagulant used to prevent strokes and blood clots in people with atrial fibrillation. Also known as Pradaxa, it works by blocking thrombin, a key protein in blood clotting. But for all its benefits, it carries a real risk: gastrointestinal bleeding, uncontrolled bleeding in the stomach or intestines. This isn’t rare—it’s one of the most common serious side effects, especially in older adults or those with a history of ulcers.

Dabigatran doesn’t need regular blood tests like warfarin, which makes it convenient. But that also means you won’t get early warnings if your blood is too thin. GI bleeding, often caused by irritation or ulcers worsened by anticoagulants, can sneak up on you. Signs include black, tarry stools; vomiting blood or material that looks like coffee grounds; sudden dizziness or weakness; or unexplained abdominal pain. If you’re on dabigatran and notice any of these, don’t wait. Call your doctor or go to the ER. Delaying care can turn a treatable bleed into a life-threatening emergency.

Some people are at higher risk. Age over 75, kidney problems, history of ulcers, or taking NSAIDs like ibuprofen or aspirin all raise the chance of bleeding. Even acid reflux meds like omeprazole can interact—though not as badly as with clopidogrel, they still add up. The key isn’t avoiding dabigatran altogether, but knowing your personal risk and managing it. Talk to your doctor about your stomach history, what other meds you’re on, and whether a lower dose might be safer. For many, the stroke prevention benefits still outweigh the risks—but only if you’re watching for trouble.

You’re not alone in this. Thousands of people take dabigatran without issues. But when GI bleeding happens, it’s often preventable with awareness. That’s why the posts below cover everything from how to track unusual symptoms with a diary, to what to do if you’re also on other blood thinners or pain meds. You’ll find real stories, clear comparisons, and practical steps—not just warnings. Whether you’re a patient, caregiver, or just trying to understand your meds, this collection gives you the tools to stay safe without fear.

DOAC Dosing in Obesity: What Works, What Doesn’t, and What to Watch For
November 27, 2025
DOAC Dosing in Obesity: What Works, What Doesn’t, and What to Watch For

Apixaban and rivaroxaban are safe and effective for obese patients at standard doses. Dabigatran increases GI bleeding risk in severe obesity. Edoxaban may need caution in extreme BMI. No need to increase doses.

Read More